These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 21115613)

  • 1. Klotho deficiency causes vascular calcification in chronic kidney disease.
    Hu MC; Shi M; Zhang J; Quiñones H; Griffith C; Kuro-o M; Moe OW
    J Am Soc Nephrol; 2011 Jan; 22(1):124-36. PubMed ID: 21115613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho: an elixir of youth for the vasculature?
    Shroff R; Shanahan CM
    J Am Soc Nephrol; 2011 Jan; 22(1):5-7. PubMed ID: 21164022
    [No Abstract]   [Full Text] [Related]  

  • 3. Klotho and kidney disease.
    Hu MC; Kuro-o M; Moe OW
    J Nephrol; 2010; 23 Suppl 16(Suppl 16):S136-44. PubMed ID: 21170871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate and Klotho.
    Kuro-O M
    Kidney Int Suppl; 2011 Apr; 79(121):S20-3. PubMed ID: 21346722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
    Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels.
    Ohnishi M; Nakatani T; Lanske B; Razzaque MS
    Circ Cardiovasc Genet; 2009 Dec; 2(6):583-90. PubMed ID: 20031638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.
    Lim K; Lu TS; Molostvov G; Lee C; Lam FT; Zehnder D; Hsiao LL
    Circulation; 2012 May; 125(18):2243-55. PubMed ID: 22492635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.
    Hu MC; Shi M; Zhang J; Quiñones H; Kuro-o M; Moe OW
    Kidney Int; 2010 Dec; 78(12):1240-51. PubMed ID: 20861825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
    Memon F; El-Abbadi M; Nakatani T; Taguchi T; Lanske B; Razzaque MS
    Kidney Int; 2008 Sep; 74(5):566-70. PubMed ID: 18528324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2.
    Patidar A; Singh DK; Thakur S; Farrington K; Baydoun AR
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial klotho expression and FGF23 effects on vascular calcification and function.
    Lindberg K; Olauson H; Amin R; Ponnusamy A; Goetz R; Taylor RF; Mohammadi M; Canfield A; Kublickiene K; Larsson TE
    PLoS One; 2013; 8(4):e60658. PubMed ID: 23577141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA; Mathew S; Davies MR; Lund RJ
    Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.
    Six I; Okazaki H; Gross P; Cagnard J; Boudot C; Maizel J; Drueke TB; Massy ZA
    PLoS One; 2014; 9(4):e93423. PubMed ID: 24695641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
    Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
    J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted klotho and chronic kidney disease.
    Hu MC; Kuro-o M; Moe OW
    Adv Exp Med Biol; 2012; 728():126-57. PubMed ID: 22396167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease.
    Paoli S; Mitsnefes MM
    Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.